Home › BIO addresses Pharmaceutical Cost Transparency Act.
 

Keywords :   


BIO addresses Pharmaceutical Cost Transparency Act.

2015-05-01 14:31:07| Industrial Newsroom - All News for Today

BIO President and CEO Jim Greenwood made statement regarding California State Assembly's burdensome legislation. "While the Assembly’s efforts to address health care costs for patients are well intended, the Pharmaceutical Cost Transparency Act of 2015 (AB 463) does nothing to improve patient access to medicines that have been put virtually out of reach by insurance company specialty tiers that have such high copays and co-insurance requirements that patients feel they no longer have insurance."

Tags: cost act addresses bio

Category:Industrial Goods and Services

Latest from this category

All news
01.10Boosting Membership Value
Industrial Goods and Services »
06.10Tropical Storm Milton Graphics
06.10Tropical Storm Milton Forecast Discussion Number 5
06.10Hurricane Kirk Graphics
06.10Tropical Storm Milton Wind Speed Probabilities Number 5
06.10Tropical Storm Milton Public Advisory Number 5
06.10Summary for Tropical Storm Milton (AT4/AL142024)
06.10Hurricane Kirk Forecast Discussion Number 29
06.10Hurricane Kirk Wind Speed Probabilities Number 29
More »